XETRA - Delayed Quote EUR

RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)

13.00 +1.20 (+10.17%)
At close: 5:36 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Dr. Tobias Kaltenbach CEO & Chairman of Management Board 507k -- 1960
Dr. Stefan Stranz CFO & Member of Management Board 543k -- 1977
Dr. Gunther Karl Weiß M.Sc. COO & Member of Management Board 625k -- 1968
Julian Schmitt Head of Investor Relations & Treasury -- -- --
Mr. Eugen Münch Chief Representative -- -- --

RHÖN-KLINIKUM Aktiengesellschaft

Salzburger Leite 1
Bad Neustadt an der Saale, 97616
Germany
49 9771 65 0 https://www.rhoen-klinikum-ag.com
Sector: 
Healthcare
Full Time Employees: 
10,017

Description

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

Corporate Governance

RHÖN-KLINIKUM Aktiengesellschaft’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 7; Board: 7; Shareholder Rights: 6; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Jun 08, 2023
    Ex-Dividend Date

Upcoming Events

May 09, 2024 - May 13, 2024
RHÖN-KLINIKUM Aktiengesellschaft Earnings Call